CAM
AZN icon

ClariVest Asset Management’s AstraZeneca AZN Stock Holding History

ClariVest Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.13K Hold
20
– – ﹤0.01% 475
2024
Q2 		$3.13K Hold
20
– – ﹤0.01% 475
2024
Q1 		$2.73K Hold
20
– – ﹤0.01% 532
2023
Q4 		$2.63K Buy
+20
New +$2.6K ﹤0.01% 513

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClariVest Asset Management's AZN Position: Q3 2024 in Review

ClariVest Asset Management held its AstraZeneca (AZN) position steady in Q3 2024 at 20 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

ClariVest Asset Management first reported a position in AZN in Q4 2023 and has held it in 4 quarters since. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • ClariVest Asset Management held 20 shares of AstraZeneca worth $3.13K as of Q3 2024.
  • ClariVest Asset Management left its AstraZeneca share count unchanged in Q3 2024.
  • AstraZeneca made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #475 holding.
  • ClariVest Asset Management first reported a position in AstraZeneca in Q4 2023 and has held it in 4 quarters since.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.